California-based biopharmaceutical company founded in 2003, focused on developing therapeutics
California-based biopharmaceutical company founded in 2003, focused on developing therapeutics. Its pipeline included RG-6125, a CDH11 inhibitor associated with neoplasms; Roche acquired the company.